Showing posts for "Global Health"
Today, IIGG releases a new policy innovation memorandum entitled “Designing a Global Coalition of Medicines Regulators.” This policy memo assesses the regulatory landscape of the global supply chain for medicines and proposes that a multilateral coalition of regulatory authorities would substantively improve the ability of public regulators to keep pace with a dynamic global marketplace. Here is an excerpt: Read more »
Coauthored by Stewart Patrick and Isabella Bennett, Assistant Director in the International Institutions and Global Governance program.
The G7 is back. Today in Brussels, it meets for the first time since 1998. The group—which includes the United States, France, the UK, Japan, Germany, Italy, and Canada—replaces the G8, after suspending Russia for its annexation of Crimea. Read more »
Having been frozen for four decades, a long-deferred debate over the “war on drugs” is finally heating up. Ever since the Nixon administration, the dominant paradigm informing U.S. and global policy towards narcotics has been prohibition. That failed approach is now being challenged by a slew of influential reports, path-breaking national policies in the Western Hemisphere, and state-level experiments within the United States. Just how turbulent the debate has become was clear at yesterday’s roundtable on the future of international drug policy, hosted by the Center for Strategic and International Studies. The United States will need to chart a new policy course if it hopes to retain credibility and influence as global attitudes toward drugs continue to evolve. Read more »
Coauthored with Jeffrey Wright, research associate in the International Institutions and Global Governance program.
Two decades ago, the vast majority of legal drugs consumed in the United States were produced domestically. Today, 80 percent of the active ingredients in medicines used by Americans are fabricated abroad. Home-grown medicines industries have exploded in developing countries like Brazil, India and China. As a result, medicines are compounded many times and cross multiple borders before they reach U.S. pharmacy shelves. Domestic oversight agencies, including the U.S. Food and Drug Administration (FDA), are therefore unable to supervise medicines’ production from start to finish, and many foreign counterpart authorities struggle to monitor and enforce adequate standards. Read more »
What world traveler hasn’t declined at least one local “delicacy”? A decade ago in Oaxaca, Mexico, I turned up my nose at chapulines, a steaming plate of toasted grasshoppers. “Tastes like chicken,” my waiter smiled unconvincingly. But overcoming disgust for “edible insects” may be the easiest way to meet global food needs, according to a fascinating, if occasionally stomach-churning, report from the UN’s Food and Agricultural Agency (FAO), based, of all places, in Rome. Read more »
The recent H7N9 flu scare in China has shown once again that we live in “an epidemiologically interdependent world.” If so, the future of global health will depend mightily on the evolving policy choices and growing material capabilities of the world’s emerging powers. My insightful colleague Yanzhong Huang explores the implications of these trends in a fascinating new CFR paper, “Enter the Dragon and the Elephant: China and India’s Participation in Global Health Governance”. Read more »
The facts are clear. The war on drugs has failed. The current global prohibition regime inflates prices of narcotics, creating extraordinary incentives for drug producers and traffickers. Efforts to eradicate supply from one country simply lead criminal syndicates to turn their attention elsewhere. This is the conclusion of a damning June 2011 report by the Global Commission on Drug Policy, composed of nineteen prominent world leaders (including former Secretary of State George Shultz). Rather than continuing to insist on policies of “zero tolerance,” and forcing all countries into “the same rigid approach to drug policy—the same laws, and the same tough approach to their enforcement,” the United Nations and the United States both need to be open to greater reform and experimentation at the national level. Read more »
The Internationalist explores how new threats and rising powers are altering world politics and how multilateral institutions can adapt.
The IIGG program identifies the institutional requirements for effective multilateral cooperation in the twenty-first century.
The Global Governance Monitor tracks, maps, and evaluates multilateral efforts to address today's global challenges, including armed conflict, public health, climate change, ocean governance, financial coordination, and nuclear proliferation.